Terveystalo Oy Class A

Terveystalo Oy's next confirmed earnings release is scheduled for February 12, 2027.

As of June 30, 2026, Terveystalo Oy has 126.81M shares outstanding.

As of June 30, 2026, Terveystalo Oy maintains a current ratio of 0.61, meaning it holds 0.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 121.74, indicating elevated leverage, while an interest coverage ratio of 10.39 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Terveystalo Oy posted a return on equity (ROE) of 13.26, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 7.83 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 5.19, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 7.77, useful for judging operating efficiency across full business cycles. The company generates approximately 167,325.23 in revenue per employee across its workforce of 8,555.25, a quick read on workforce productivity versus industry peers. Inventory turnover of 64.94 indicates how many times Terveystalo Oy sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Terveystalo Oy recorded 22.28M in income tax expense. That works out to an effective tax rate of 20.86, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 106.82M, leaving 84.54M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 20, 2026, Terveystalo Oy's stock has declined approximately 44.48% over the past 52 weeks.

Over the twelve months ended June 30, 2026, Terveystalo Oy generated 1.43B in revenue and converted that into 84.54M in net income, yielding earnings per share of 0.66. EBITDA reached 247.00M, while operating income came in at 132.07M.

As of June 30, 2026, Terveystalo Oy holds 99.97M in cash and equivalents against 739.63M in total debt, resulting in a net debt position of 418.71M. Total book value stands at 607.56M, with working capital of -162.92M providing operational flexibility.

Terveystalo Oy produced 183.82M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -62.95M in capital expenditures, free cash flow totaled 120.87M - equivalent to 0.95 per share.

Over the twelve months ended June 30, 2026, Terveystalo Oy posted a gross margin of 59.83, reflecting its pricing power and cost economics. The operating margin of 9.23 and net profit margin of 5.91 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Terveystalo Oy paid dividends of 0.91 per share. The dividend payout ratio of 137.03 exceeds 100%, meaning the company is distributing more than it earns and funding the dividend from cash reserves, asset sales, or borrowing, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth.